A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors | MicrobiomeTrials← Back to trialsNCT07897721
A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-11-09Est. Completion: 2030-03-22
Enrollment target: 268 participants Other microbiome trials you might be interested in
Locally Advanced Hypopharyngeal Squamous Cell CarcinomaLocally Advanced Laryngeal Squamous Cell CarcinomaLocally Advanced Oral Cavity Squamous Cell CarcinomaLocally Advanced Oropharyngeal Squamous Cell Carcinoma
This phase III trial compares cetuximab to chemotherapy, carboplatin and paclitaxel, with intensity modulated radiation …
Birmingham, United StatesEst. completion Nov 30, 2035
Lung Non-Small Cell CarcinomaLung Non-Small Cell Squamous Carcinoma
Lung Non-Squamous Non-Small Cell Carcinoma
Stage II Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Stage IIIB Lung Cancer AJCC v8
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of …
Anchorage, United StatesEst. completion Jan 31, 2030
Breast Cancer
In recent years, the successful application of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) has transformed the trea…
Multiple LocationsEst. completion Jun 30, 2028